Cardiac Tissue Doppler in Steroid Users

Abstract

Anabolic steroids cause a variety of side effects, among them a slight concentric left ventricular hypertrophy. The objective of the present study was to clarify if they also induce alterations in left ventricular function. 14 male bodybuilders with substantial intake of anabolic steroids (users) were examined by standard echocardiography and cardiac tissue Doppler imaging. They were compared to 11 steroid-free strength athletes (non-users) and 15 sedentary control subjects. Users showed an increased left ventricular muscle mass index. The ratio of peak transmitral blood flow velocities during early diastolic filling and atrial contraction did not differ between groups (users: 1.4 ± 0.3; non-users: 1.7 ± 0.5; controls: 1.4 ± 0.4). In contrast an analogous tissue Doppler parameter, the ratio of myocardial velocities during early and late ventricular filling in the basal septum, was significantly lower in users (1.2 ± 0.4) when compared to non-users (1.6 ± 0.5) or controls (1.6 ± 0.6). The velocity gradient during myocardial E-wave in the posterior wall showed significantly lower values in users (3.8 ± 1.3 1/s) as compared to controls (5.8 ± 2.5 1/s). There were no differences in systolic function. Summarizing strength athletes abusing anabolic steroids show negative alterations in diastolic function.

Key words

cardiac function - echocardiography - anabolic steroids - tissue Doppler imaging - strength training

References

• 1 Aeschenbacher B C, Hutter D, Fuhrer J, Weidemann P, Delacretaz E, Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.  Am J Hypertens. 2001;  14 106-113
• 2 Alen M, Hakkinen K, Komi P V. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids.  Acta Physiol Scand. 1984;  122 535-544
• 3 Cardim N, Castela S, Cordeiro R, Longo S, Ferreira T, Pereira A, Gouveia A, Reis R P, Correia J M. Tissue doppler imaging assessment of long axis left ventricular function in hypertrophic cardiomyopathy.  Rev Port Cardiol. 2002;  21 953-985
• 4 Claessens P J, Claessens C W, Claessens M M, Claessens M C, Claessens J E. Supernormal left ventricular diastolic function in triathletes.  Tex Heart Inst J. 2001;  28 102-110
• 5 Colan S D, Sanders S P, MacPherson D, Borow K M. Left ventricular diastolic function in elite athletes with physiologic cardiac hypertrophy.  J Am Coll Cardiol. 1985;  6 545-549
• 6 D'Andrea A, Caso P, Severino S, Galderisi M, Sarubbi B, Limongelli G, Cice G, D'Andrea L, Scherillo M, Mininni N, Calabro R. Effects of different training protocols on left ventricular myocardial function in competitive athletes: A Doppler tissue imaging study.  Ital Heart J. 2002;  3 34-40
• 7 De Marchi S F, Allemann Y, Seiler C. Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: Relations between hypertrophy and diastolic function.  Heart. 2000;  83 678-684
• 8 De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: An echocardiographic study of left ventricle morphology and function.  Int J Sports Med. 1991;  12 408-412
• 9 Devereux R B, Alonso D R, Lutas E M, Gottlieb G J, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings.  Am J Cardiol. 1986;  57 450-458
• 10 Dickerman R D, Schaller F, McConathy W J. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid use.  Cardiology. 1998;  90 145-148
• 11 Dickerman R D, Schaller F, Zachariah N Y, McConathy W J. Left ventricular size and function in elite bodybuilders using anabolic steroids.  Clin J Sport Med. 1997;  7 90-93
• 12 Du Bois D, Du Bois E. A formula to estimate the approximate surface area if height and weight be known.  Arch Intern Med. 1916;  17 863-871
• 13 El-Sherif N. Electrophysiological basis of ventricular late potentials.  Prog Cardiovasc Dis. 1993;  35 417-427
• 14 Hartgens F, Cheriex E, Kuipers H. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.  Int J Sports Med. 2004;  24 344-351
• 15 Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes.  Sports Med. 2004;  34 513-554
• 16 Ho C Y, Sweitzer N K, McDonough B, Maron B J, Casey S A, Seidman J G, Seidman C E, Solomon S D. Assessment of diastolic function with doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy.  Circulation. 2002;  105 2992-2997
• 17 LeGros T, MacConnell D, Murry T, Edavettal M, Racey-Burns L A, Shepherd R E, Burns A H. The effects of 17 alpha-methyltestosterone on myocardial function in vitro.  Med Sci Sports Exerc. 2000;  32 897-903
• 18 Lombardi R, Betocchi S, Losi M A, Tocchetti C G, Aversa M, Miranda M, D'Alessandro G, Cacace A, Ciampi Q, Chiariello M. Myocardial collagen turnover in hypertrophic cardiomyopathy.  Circulation. 2003;  108 1455-1460
• 19 Miyachi M, Kawano H, Sugawara J, Takahashi K, Hayashi K, Yamazaki K, Tabata I, Tanaka H. Unfavourable effects of resistance training on central arterial compliance: A randomized intervention study.  Circulation. 2004;  110 2858-2863
• 20 Nagueh S F, McFalls J, Meyer D, Hill R, Zoghbi W A, Tam J W, Quinones M A, Roberts R, Marian A J. Tissue doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.  Circulation. 2003;  108 395-398
• 21 Naqvi T, Neyman G, Broyde A, Mustafa J, Siegel R. Comparison of myocardial tissue doppler with transmitral flow doppler in left ventricular hypertrophy.  J Am Soc Echocardiogr. 2001;  14 1153-1160
• 22 Nieminen M, Ramo M, Viitasalo M, Heikkila P, Karjalainen J, Mantysaari M, Heikkila J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters.  Eur Heart J. 1996;  17 1576-1583
• 23 Nottin S, Nguyen L D, Terbah M, Obert P. Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue doppler imaging.  Am J Cardiol. 2006;  97 912-915
• 24 Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M, Baldo-Enzi G. Cardiovascular effects of anabolic steroids in weight-trained subjects.  J Clin Pharmacol. 1996;  36 1132-1140
• 25 Palka P, Lange A, Donnelly J, Scalia G, Burstow D, Nihoyanopoulos P. Doppler tissue echocardiographic features of cardiac amyloidosis.  J Am Soc Echocardiogr. 2002;  15 1353-1360
• 26 Palka P, Lange A, Fleming A, Donnelly J, Dutka D, Starkey I, Shaw T, Sutherland G, Fox K. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension.  J Am Coll Cardiol. 1997;  30 760-768
• 27 Palka P, Macdonald G, Lange A, Burstow D J. The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis.  J Am Soc Echocardiogr. 2002;  15 884-890
• 28 Pearson A C, Schiff M, Mrosek D, Labovitz A J, Williams G A. Left ventricular diastolic function in weight lifters.  Am J Cardiol. 1986;  58 1254-1259
• 29 Pieroni M, Chimenti C, Ricci R, Sale P, Russo M A, Frustaci A. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.  Circulation. 2003;  107 1978-1984
• 30 Sachtleben T R, Berg K E, Elias B A, Cheatham J P, Felix G L, Hofschire P J. The effects of anabolic steroids on myocardial structure and cardiovascular fitness.  Med Sci Sports Exerc. 1993;  25 1240-1245
• 31 Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W. Athlete's heart: Right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging.  J Am Coll Cardiol. 2002;  40 1856-1863
• 32 Schmidt-Trucksäss A, Schmid A, Häussler C, Huber M, Huonker M, Keul J. Left ventricular wall motion during diastolic filling in endurance-trained athletes.  Med Sci Sports Exerc. 2001;  33 189-195
• 33 Shimizu Y, Uematsu M, Nagaya N, Yamagishi M, Yamamoto H, Miyatake K, Imazu M, Kohno N. Myocardial velocity gradient reflects the severity of myocardial damage regardless of the presence or absence of mitral regurgitation.  J Am Soc Echocardiogr. 2003;  16 246-253
• 34 Spach M S, Dolber P C. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age.  Circ Res. 1986;  58 356-371
• 35 Thompson P D, Sadaniantz A, Cullinane E M, Bodziony K S, Catlin D H, Torek-Both G, Douglas P S. Left ventricular function is not impaired in weight-lifters who use anabolic steroids.  J Am Coll Cardiol. 1992;  19 278-282
• 36 Urhausen A, Albers T, Kindermann W. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers.  J Steroid Biochem Mol Biol. 2003;  84 369-375
• 37 Urhausen A, Hölpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids.  Eur J Appl Pysiol. 1989;  58 633-640
• 38 Urhausen A, Kindermann W. Sports-specific adaptations and differentiations of the athlete's heart.  Sports Med. 1999;  28 237-244
• 39 Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J, Miwa T, Sugawara M, Yamaguchi Y, Ookawara T, Suzuki K, Hori M. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive hearts.  Cardiovasc Res. 2002;  55 76-82
• 40 Yeater R, Reed C, Ullrich I, Morise A, Borsch M. Resistance trained athletes using or not using anabolic steroids compared to runners: Effects on cardiorespiratory variables, body composition, and plasma lipids.  Br J Sports Med. 1996;  30 11-14
• 41 Yuda S, Short L, Leano R, Marwick T. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: A study of ultrasound tissue characterization and strain.  Clin Sci. 2002;  103 283-293